PRECIPIO, INC. (PRPO) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 73.00K USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 252.00K USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 21.32M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $73.00K | $252.00K | (m) | (m) | $21.32M | (m) |
| 2026-03-31 | (m) | (m) | $30.00K | $40.00K | (m) | (m) | $20.80M | (m) |
| 2025-12-31 | (m) | (m) | $30.00K | $47.00K | (m) | (m) | $21.32M | (m) |
| 2025-09-30 | (m) | (m) | $30.00K | $55.00K | (m) | (m) | $21.15M | (m) |
| 2025-06-30 | (m) | (m) | $29.00K | $62.00K | (m) | (m) | $18.82M | (m) |
| 2025-03-31 | (m) | (m) | $147.00K | $70.00K | (m) | (m) | $17.79M | (m) |
| 2024-12-31 | (m) | (m) | $297.00K | $77.00K | (m) | (m) | $17.00M | (m) |
| 2024-09-30 | (m) | (m) | $444.00K | $84.00K | (m) | (m) | $16.95M | (m) |
| 2024-06-30 | (m) | (m) | $249.00K | $92.00K | (m) | (m) | $17.32M | (m) |
| 2024-03-31 | (m) | (m) | $133.00K | $99.00K | (m) | (m) | $16.62M | (m) |
| 2023-12-31 | (m) | (m) | $235.00K | $106.00K | (m) | (m) | $18.10M | (m) |
| 2023-09-30 | (m) | (m) | $334.00K | $113.00K | (m) | (m) | $19.05M | (m) |
| 2023-06-30 | (m) | (m) | $27.00K | $120.00K | (m) | (m) | $19.47M | (m) |
| 2023-03-31 | (m) | (m) | $142.00K | $127.00K | (m) | (m) | $19.42M | (m) |
| 2022-12-31 | (m) | (m) | $255.00K | $134.00K | (m) | (m) | $21.50M | (m) |
| 2022-09-30 | (m) | (m) | $367.00K | $141.00K | (m) | (m) | $23.55M | (m) |
| 2022-06-30 | (m) | (m) | $26.00K | $148.00K | (m) | (m) | $25.98M | (m) |
| 2022-03-31 | (m) | (m) | $26.00K | $154.00K | (m) | (m) | $27.97M | (m) |
| 2021-12-31 | (m) | (m) | $26.00K | $160.00K | (m) | (m) | $30.44M | (m) |
| 2021-09-30 | (m) | (m) | $26.00K | $167.00K | (m) | (m) | $31.61M | (m) |
| 2021-06-30 | (m) | (m) | $25.00K | $174.00K | (m) | (m) | $33.54M | (m) |
| 2021-03-31 | (m) | (m) | $30.00K | $180.00K | (m) | (m) | $20.42M | (m) |
| 2020-12-31 | (m) | (m) | $648.00K | $362.00K | (m) | (m) | $20.71M | (m) |
| 2020-09-30 | (m) | (m) | $530.00K | $500.00K | (m) | (m) | $20.72M | (m) |
| 2020-06-30 | (m) | (m) | $391.00K | $631.00K | (m) | (m) | $19.03M | (m) |
| 2020-03-31 | (m) | (m) | $180.00K | $194.00K | (m) | (m) | $19.00M | (m) |
| 2019-12-31 | (m) | (m) | $321.00K | $198.00K | (m) | (m) | $19.51M | (m) |
| 2019-09-30 | (m) | (m) | $454.00K | $207.00K | (m) | (m) | $22.52M | (m) |
| 2019-06-30 | (m) | (m) | $103.00K | $223.00K | (m) | (m) | $22.20M | (m) |
| 2019-03-31 | (m) | (m) | $161.00K | $238.00K | (m) | (m) | $21.64M | (m) |
| 2018-12-31 | (m) | (m) | $263.00K | $253.00K | (m) | (m) | $21.61M | (m) |
| 2018-09-30 | (m) | (m) | $653.00K | $1.04M | (m) | (m) | $24.65M | (m) |
| 2018-06-30 | (m) | (m) | $831.00K | $2.66M | (m) | (m) | $25.89M | (m) |
| 2018-03-31 | (m) | (m) | $676.00K | $2.89M | (m) | (m) | $26.09M | (m) |
| 2017-12-31 | (m) | (m) | $587.00K | $2.83M | (m) | (m) | $27.26M | (m) |
| 2017-09-30 | (m) | (m) | $42.00K | $0.00 | (m) | (m) | $34.98M | (m) |
| 2017-06-30 | (m) | (m) | $513.00K | $0.00 | (m) | (m) | $37.01M | (m) |
| 2017-03-31 | (m) | (m) | $7.37M | $0.00 | (m) | (m) | $1.23M | (m) |
| 2016-12-31 | (m) | (m) | $7.81M | $0.00 | (m) | (m) | $1.26M | (m) |
| 2016-09-30 | (m) | (m) | $7.81M | $0.00 | (m) | (m) | $2.08M | (m) |
| 2016-06-30 | (m) | (m) | $7.81M | $0.00 | (m) | (m) | $3.09M | (m) |
| 2016-03-31 | (m) | (m) | $7.35M | $0.00 | (m) | (m) | $3.59M | (m) |
| 2015-12-31 | (m) | (m) | $7.60M | $0.00 | (m) | (m) | $4.82M | (m) |
| 2015-09-30 | (m) | (m) | $6.28M | $525.00K | (m) | (m) | $24.45M | (m) |
| 2015-06-30 | (m) | (m) | $2.83M | $4.85M | (m) | (m) | $31.41M | (m) |
| 2015-03-31 | (m) | (m) | $523.00K | $7.92M | (m) | (m) | $34.49M | (m) |
| 2014-12-31 | (m) | (m) | $462.00K | $7.38M | (m) | (m) | $30.01M | (m) |
| 2014-09-30 | (m) | (m) | $1.38M | $5.61M | (m) | (m) | $30.85M | (m) |
| 2014-06-30 | (m) | (m) | $691.00K | $6.21M | (m) | (m) | $31.09M | (m) |
| 2014-03-31 | (m) | (m) | $0.00 | $3.76M | (m) | (m) | $30.72M | (m) |
| 2013-12-31 | (m) | (m) | $242.00K | $6.32M | (m) | (m) | $30.28M | (m) |
| 2013-09-30 | (m) | (m) | $1.09M | $5.47M | (m) | (m) | $33.18M | (m) |
| 2013-06-30 | (m) | (m) | $727.00K | $7.27M | (m) | (m) | $39.36M | (m) |
| 2013-03-31 | (m) | (m) | $364.00K | $6.07M | (m) | (m) | $41.40M | (m) |
| 2012-12-31 | (m) | (m) | $6.17M | $0.00 | (m) | (m) | $38.79M | (m) |
| 2012-09-30 | (m) | (m) | $6.96M | $448.00K | (m) | (m) | $42.89M | (m) |
| 2012-06-30 | (m) | (m) | $6.06M | $1.34M | (m) | (m) | $44.67M | (m) |
| 2012-03-31 | (m) | (m) | $7.29M | $1.34M | (m) | (m) | $47.18M | (m) |
| 2011-12-31 | (m) | (m) | $3.70M | $4.94M | (m) | (m) | $33.56M | (m) |
| 2011-09-30 | (m) | (m) | $1.23M | $7.41M | (m) | (m) | $29.97M | (m) |
| 2011-06-30 | (m) | (m) | (m) | $7.41M | (m) | (m) | $30.70M | (m) |
| 2010-12-31 | (m) | (m) | (m) | $8.64M | (m) | (m) | $32.03M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |